Table 1 Comparison of the baseline and clinical characteristics according to the presence of respiratory virus co-infection
Variable, n (%) or mean ± SD | Respiratory virus non-coinfection group | Respiratory virus coinfection group | P value |
|---|---|---|---|
Baseline characteristics | |||
N (%) | 82 (56.6) | 63 (43.4) | NA |
Age at the diagnosis of MP pneumonia, mean ± SD, years | 6.7 ± 4.2 | 5.0 ± 3.1 | 0.008 |
Male, n (%) | 40/42 (48.8) | 35/63 (46.7) | 0.418 |
Referred cases, n (%) | 80/82 (97.6) | 61/63 (96.8) | 0.789 |
Comorbid allergic diseases | |||
Atopic dermatitis | 1/82 (1.2) | 2/63 (3.2) | 0.412 |
Allergic rhinitis | 39/82 (47.6) | 38/63 (60.3) | 0.127 |
Asthma | 6/82 (7.3) | 11/63 (17.5) | 0.060 |
Clinical characteristics | |||
Duration between symptom onset and admission, days | 5.7 ± 3.1 | 7.9 ± 4.3 | 0.001 |
Duration of fever during illness, days | 5.7 ± 3.8 | 7.7 ± 4.7 | 0.006 |
Hemoptysis | 3/82 (3.7) | 0/63 (0.0) | 0.125 |
Fever | 81/82 (98.8) | 63/63 (100.0) | 0.379 |
Oxygen supplementation | 6/82 (7.3) | 3/63 (4.8) | 0.527 |
ICU admission | 0/82 | 0/63 | NA |
Response to treatment of MP pneumonia | 0.019 | ||
Good response | 38/82 (46.3) | 16/62 (25.8) | |
Slow response | 38/82 (46.3) | 35/62 (56.5) | |
No/poor response | 6/82 (7.3) | 11/62 (17.7) | |
Total duration of hospitalization, days | 8.0 ± 4.3 | 9.8 ± 5.2 | 0.033 |